Cargando…
Opportunities of next-generation sequencing in non-muscle invasive bladder cancer outcome prediction
Bladder cancer (BC) is a common disease in both sexes and majority of cases present as non-muscle invasive BC (NMIBC). The percentage of NMIBC progressing to muscle invasive BC (MIBC) varies between 25% and 75% and currently there are no reliable biomarkers that may predict the outcome of high-risk...
Autores principales: | Pang, Karl H., Esperto, Francesco, Noon, Aidan P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760392/ https://www.ncbi.nlm.nih.gov/pubmed/29354491 http://dx.doi.org/10.21037/tau.2017.10.04 |
Ejemplares similares
-
Selection of patients and benefit of immediate radical cystectomy for non-muscle invasive bladder cancer
por: Pang, Karl H., et al.
Publicado: (2019) -
Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients
por: Conroy, Samantha, et al.
Publicado: (2022) -
Prognostic factors of non-muscle invasive bladder cancer: a study based on next-generation sequencing
por: Shao, Yanxiang, et al.
Publicado: (2021) -
Next-generation sequencing in non-muscle-invasive bladder cancer—a step towards personalized medicine for a superficial bladder tumor
por: Butterfield, Andrew, et al.
Publicado: (2017) -
Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder Cancer
por: Ward, Douglas G., et al.
Publicado: (2016)